MMPP
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Product Specifications
CAS Number
1895957-18-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
270.32
Molecular Formula
C17H18O3
Notes
Research use only, not for human use.
Receptor
STAT | VEGFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1058947-01 0.02 mg (E-Coli)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details 
MBS1058947-02 0.1 mg (E-Coli)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details MBS1058947-03 0.02 mg (Yeast)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details MBS1058947-04 0.1 mg (Yeast)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details 
MBS1058947-05 0.02 mg (Baculovirus)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details MBS1058947-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus amyloliquefaciens Ribosome maturation factor RimM (rimM)
Ask
View Details